Roberto Marchioli
Roberto Marchioli
Quintiles
Verified email at quintiles.com
Title
Cited by
Cited by
Year
Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
21122*2014
Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Circulation 131 (4), 434-441, 2015
150432015
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
M Flather
The Lancet 376 (9753), 1670-1681, 2010
5469*2010
Dietary supplementation with n3 polyunsaturated fatty acids and vitamin E after MI: results of the
GP Trial
Lancet 354, 447-55, 1999
2579*1999
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
N Sattar, D Preiss, HM Murray, P Welsh, BM Buckley, AJM de Craen, ...
The Lancet 375 (9716), 735-742, 2010
25582010
Heart disease and stroke statistics: 2006 update
American Heart Association
http://circ. ahajournals. org/cgi/reprint/CIRCULATIONAHA. 105.171600 v1, 2006
20452006
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio …
R Marchioli, F Barzi, E Bomba, C Chieffo, D Di Gregorio, R Di Mascio, ...
Circulation 105 (16), 1897-1903, 2002
17732002
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
J Danesh, S Lewington, SG Thompson, G Lowe, R Collins, JB Kostis, ...
Jama 294 (14), 1799-1809, 2005
13712005
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
E Romagna
13092008
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
L Tavazzi, AP Maggioni, R Marchioli, S Barlera, MG Franzosi, R Latini, ...
Lancet (London, England) 372 (9645), 1231-1239, 2008
10902008
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
L Tavazzi, AP Maggioni, R Marchioli, S Barlera, MG Franzosi, R Latini, ...
Lancet (London, England) 372 (9645), 1231-1239, 2008
10892008
Efficacy and safety of low-dose aspirin in polycythemia vera
R Landolfi, R Marchioli, J Kutti, H Gisslinger, G Tognoni, C Patrono, ...
New England Journal of Medicine 350 (2), 114-124, 2004
10182004
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera
R Marchioli, G Finazzi, R Landolfi, J Kutti, H Gisslinger, C Patrono, ...
Journal of Clinical Oncology 23 (10), 2224-2232, 2005
6512005
Cardiovascular events and intensity of treatment in polycythemia vera
R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ...
N Engl J Med 368, 22-33, 2013
6292013
A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid …
G Finazzi, R Marchioli, V Brancaccio, P Schinco, F Wisloff, J Musial, ...
Journal of Thrombosis and Haemostasis 3 (5), 848-853, 2005
5862005
A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease
Coronary Artery Disease (C4D) Genetics Consortium
Nature genetics 43 (4), 339, 2011
5352011
Clinical profile of homozygous JAK2 617V> F mutation in patients with polycythemia vera or essential thrombocythemia
AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ...
Blood 110 (3), 840-846, 2007
5252007
Secondary prevention through cardiac rehabilitation: position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology
P Giannuzzi, H Saner, H Björnstad, P Fioretti, M Mendes, A Cohen-Solal, ...
European heart journal 24 (13), 1273-1278, 2003
499*2003
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ...
The Lancet 385 (9965), 351-361, 2015
4922015
Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update
G Maresca, A Di Blasio, R Marchioli, G Di Minno
Arteriosclerosis, thrombosis, and vascular biology 19 (6), 1368-1377, 1999
4781999
The system can't perform the operation now. Try again later.
Articles 1–20